SLDB

NASDAQ · Biotechnology

Solid Biosciences Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$8.58

-0.13 (-1.49%)

As of Aug 8, 1:53 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 19 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target +27.0% upside

Low Target $9.47

Average Target $10.90

High Target $14.24

Current Price $8.58

Current
$8.58

Target
$10.90

$9.47 $10.90 avg $14.24

Scenario Analysis

Bear Case

$9.47

10.4%

Low target

Base Case

$10.90

+27.0%

Avg target

Bull Case

$14.24

+66.0%

High target

Risk/Reward

6.4x

Highly favorable

Price in Context

52-Week High

$11.45

-25.1% from high

52-Week Low

$3.79

+126.4% from low

Target vs 52W High

$10.90

-4.8% vs high

Next Earnings Report

Aug 10, 2026

tomorrow

EPS Est: $-0.48

Earnings in 1 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	44	64%	$91.45	-56.0%